title: [Diagnostics and treatment strategies for soft tissue sarcomas].
abstract: Soft tissue sarcomas (STS) represent a rare entity of all malignant tumors (1%). Thus, an in-depth understanding of multidisciplinary treatment strategies may not be sufficiently present at all operative units. Consecutively, optimal diagnostic and therapeutical pathways may not be applied. Magnetic resonance imaging (MRI) is the procedure of choice in diagnosing STS. Biopsies should be performed in specialized centers. Identification of cytogenetic factors has become more important for the typing and prognosis of STS. Management of STS should employ multimodal treatment concepts (Oncology, Radiotherapy, Surgical Oncology). The decision on whether radiotherapy, chemotherapy or another option is indicated should be taken by an interdisciplinary tumor board, which also determines the sequence of treatment in relation to resection. To obtain sufficient information from histopathologic examination of the resected tumor, a clear and distinct definition of critical margins and topography by the surgeon is essential. Following these concepts, optimal local tumor control associated with resections preserving function and limbs is achieved without impairment of overall prognosis. Tumor resection alone, without previous evaluation and where appropriate adopting multimodal treatment strategies, no longer meets modern standards. After primary treatment is complete, patients have to be enrolled in a standardized follow-up program.
authors.affiliation: Westdeutsches Tumorzentrum Essen. georg.taeger@uni-essen.de
authors.forename: G
authors.initials: G
authors.lastname: Taeger
authors.forename: S
authors.initials: S
authors.lastname: Ruchholtz
authors.forename: J
authors.initials: J
authors.lastname: Schütte
authors.forename: D
authors.initials: D
authors.lastname: Nast-Kolb
mesh_terms: D001706:Biopsy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003238:Connective Tissue / Q000473:pathology; D003952:Diagnostic Imaging; D005121:Extremities / Q000601:surgery*; D005500:Follow-Up Studies; D006801:Humans; D009367:Neoplasm Staging; D010348:Patient Care Team; D018714:Radiotherapy, Adjuvant; D012509:Sarcoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*